Found 11 matching trials
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors PHASE1 This is an open-label, multi-center study of Phase Ib/II study to assess th...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin PHASE2 This study is an open, exploratory clinical study. Eligible patients with a...
Show More Location
Fudan University Cancer Hospital
Learn More & Join Trial
A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma PHASE2 This is a single term, open label, single Center, Phase II Trial. The study...
Show More Location
Multiple Locations
Learn More & Join Trial
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer PHASE2 This study is a single-arm, open-label, exploratory clinical study, the mai...
Show More Learn More & Join Trial
Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients PHASE2 This study is a single-center, open, single-arm, phase II clinical trial. E...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer PHASE2 This is an open-label, multi-center, multi-corhort Phase II study of Envafo...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma PHASE2 TACE lays a theoretical foundation for synergistic enhancement in combinati...
Show More Location
Multiple Locations
Learn More & Join Trial
D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC N/A This is a prospective, single-arm, multicenter, phase II trial to evaluate ...
Show More Location
Fujian Provincial Hospital
Learn More & Join Trial
Survival Analysis: TACE vs. Combination Therapy in HCC N/A This retrospective observational study aimed to assess potential improvemen...
Show More Location
First Affiliated Hospital, Medical College of Zhejiang University
Learn More & Join Trial
Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer PHASE1 Advanced biliary tract cancer has a poor prognosis and limited efficacy wit...
Show More Location
Study Chair Liu Chang , West China Hospital, Chengdu, Sichuan 610041
Learn More & Join Trial